Lisa Cronin

机构：University of South Florida, Boehringer Ingelheim (Brazil), Boehringer Ingelheim (France), Boehringer Ingelheim (United States)

发表论文 41 篇 · 总被引 2780 次 · h-index 16

代表论文

• The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial (2024 · Nephrology Dialysis Transplantation · 被引 66)
• Antithrombotic Treatment of Embolic Stroke of Undetermined Source (2020 · Stroke · 被引 34)
• Aldosterone synthase inhibitor ( BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double‐blind, placebo‐controlled, Phase I trial (2024 · Diabetes Obesity and Metabolism · 被引 33)
• Methods Article for a Study Protocol: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in Chronic Kidney Disease (2023 · American Journal of Nephrology · 被引 20)
• Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE‐SPECT ESUS Trial (2022 · Journal of the American Heart Association · 被引 15)
• WCN24-1550 ALDOSTERONE SYNTHASE INHIBITION WITH OR WITHOUT BACKGROUND SODIUM GLUCOSE COTRANSPORTER 2 INHIBITION IN CKD: A PHASE II CLINICAL TRIAL (2024 · Kidney International Reports · 被引 2)